Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Immunovant, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 6 insiders, $1.12M in total
- Insiders trading
- 6
- Net value
- −$1.12M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Immunovant, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Van Tuyl Christopher | Chief Legal Officer | 176,545 | Sep 25, 2026 | 8 |
| Pande Atul | Director | 116,731 | Aug 28, 2026 | 6 |
| Gloria Melanie | Chief Operating Officer | 219,301 | Aug 21, 2026 | 8 |
| Girao Tiago | Chief Financial Officer | 240,798 | Jul 24, 2026 | 4 |
| Stout Jay S | Chief Technology Officer | 205,341 | Jul 24, 2026 | 10 |
| Venker Eric | Chief Executive Officer | 254,280 | Jul 6, 2026 | 3 |
| Fromkin Andrew J. | Director | 74,382 | May 29, 2026 | 3 |
| Susman Robert Graham | Director | 36,394 | May 1, 2026 | 2 |
| Torti Frank | Director | 1,009,228 | Apr 9, 2026 | 1 |
| Bauer Jake | Director | 38,896 | Apr 9, 2026 | 1 |
| Hughes Douglas J. | Director | 134,653 | Apr 9, 2026 | 2 |
| Roivant Sciences Ltd. | Director, 10% Owner | 113,317,007 | Dec 12, 2025 | 1 |
| Geffner Michael | Chief Medical Officer | 217,958 | Oct 24, 2025 | 2 |
| Salzmann Peter | Chief Executive Officer | 1,178,191 | Apr 17, 2025 | 0 |
| Barnett Eva Renee | Chief Financial Officer | 396,774 | Apr 17, 2025 | 0 |
| Migausky George V | Director | 137,251 | Apr 3, 2025 | 0 |
| Macias William L. | Chief Medical Officer | 357,353 | Feb 21, 2025 | 0 |
| Levine Mark S. | Chief Legal Officer | 319,228 | Nov 22, 2024 | 0 |
| Butchko Julia G. | Chief Development Officer | 440,959 | Aug 23, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2023 (view filing) | Apr 18 | 1 day | Barnett Eva ReneeChief Financial Officer | SSale | −3.42K | $15.27 | −$52.3K | −1.0%352.6K after | |
| Apr 19, 2023 (view filing) | Apr 18 | 1 day | Butchko Julia G.Chief Development Officer | SSale | −1.54K | $15.27 | −$23.6K | −0.4%430.1K after | |
| Apr 19, 2023 (view filing) | Apr 18 | 1 day | Salzmann PeterChief Executive Officer | SSale | −3.40K | $15.27 | −$51.8K | −0.3%1.23M after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Macias William L.Chief Medical Officer | SSale | −537 | $18.24 | −$9.79K | −0.2%263.0K after | |
| Jan 27, 2023 (view filing) | Jan 26 | 1 day | Levine Mark S.Chief Legal Officer | SSale | −10.2K | $18.51 | −$188.0K | −4.0%245.7K after | |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Salzmann PeterChief Executive Officer | SSale | −4.02K | $16.80 | −$67.6K | −0.4%993.9K after | |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −60.5K | $16.79 | −$1.02M | −15.4%331.4K after | 2 lots |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Barnett Eva ReneeChief Financial Officer | SSale | −4.51K | $16.75 | −$75.5K | −1.7%268.3K after | 2 lots |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Macias William L.Chief Medical Officer | SSale | −44.6K | $16.75 | −$746.3K | −14.5%263.5K after | 2 lots |
| Oct 25, 2022 (view filing) | Oct 21 | 4 days | Macias William L.Chief Medical Officer | SSale | −341 | $9.67 | −$3.30K | −0.1%308.1K after | |
| Oct 17, 2022 (view filing) | Oct 13 | 4 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −928 | $9.18 | −$8.52K | −0.2%391.9K after | |
| Oct 17, 2022 (view filing) | Oct 13 | 4 days | Salzmann PeterChief Executive Officer | SSale | −2.79K | $9.18 | −$25.6K | −0.3%998.0K after | |
| Oct 13, 2022 (view filing) | Oct 11 | 2 days | Barnett Eva ReneeChief Financial Officer | SSale | −12.5K | $9.44 | −$118.0K | −4.4%272.9K after | |
| Oct 7, 2022 (view filing) | Oct 6 | 1 day | Roivant Sciences Ltd.10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +416.7K | $6.00 | +$2.50M | +0.6%73.8M after | |
| Oct 4, 2022 (view filing) | Sep 30 | 4 days | Pande AtulDirector | PPurchase | +15.0K | $5.60 | +$84.0K | +300.0%20.0K after | |
| Sep 29, 2022 (view filing) | Sep 28 | 1 day | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −535 | $4.67 | −$2.50K | −0.1%392.8K after | |
| Sep 29, 2022 (view filing) | Sep 28 | 1 day | Salzmann PeterChief Executive Officer | SSale | −1.60K | $4.67 | −$7.50K | −0.2%1.00M after | |
| Sep 29, 2022 (view filing) | Sep 29 | Same day | Torti FrankDirector | PPurchase | +20.0K | $5.81 | +$116.2K | +5.4%393.4K after | |
| Sep 1, 2022 (view filing) | Aug 30 | 2 days | Salzmann PeterChief Executive Officer | SSale | −1.64K | $5.83 | −$9.58K | −0.2%1.00M after | |
| Sep 1, 2022 (view filing) | Aug 30 | 2 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −548 | $5.83 | −$3.19K | −0.1%393.4K after | |
| Jul 29, 2022 (view filing) | Jul 27 | 2 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −510 | $4.27 | −$2.18K | −0.2%281.1K after | |
| Jul 29, 2022 (view filing) | Jul 27 | 2 days | Salzmann PeterChief Executive Officer | SSale | −1.53K | $4.27 | −$6.52K | −0.3%552.7K after | |
| Jul 26, 2022 (view filing) | Jul 22 | 4 days | Macias William L.Chief Medical Officer | SSale | −322 | $4.70 | −$1.51K | −0.2%195.6K after | |
| Jul 1, 2022 (view filing) | Jun 29 | 2 days | Salzmann PeterChief Executive Officer | SSale | −1.38K | $4.02 | −$5.53K | −0.2%554.3K after | |
| Jul 1, 2022 (view filing) | Jun 29 | 2 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −460 | $4.02 | −$1.85K | −0.2%281.6K after | |
| May 25, 2022 (view filing) | May 24 | 1 day | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −492 | $3.79 | −$1.86K | −0.2%282.1K after | |
| May 25, 2022 (view filing) | May 24 | 1 day | Salzmann PeterChief Executive Officer | SSale | −1.47K | $3.79 | −$5.58K | −0.3%555.6K after | |
| Apr 29, 2022 (view filing) | Apr 27 | 2 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −541 | $4.72 | −$2.55K | −0.2%282.6K after | |
| Apr 29, 2022 (view filing) | Apr 27 | 2 days | Salzmann PeterChief Executive Officer | SSale | −1.62K | $4.72 | −$7.66K | −0.3%557.1K after | |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Macias William L.Chief Medical Officer | SSale | −1.39K | $4.98 | −$6.93K | −0.7%195.9K after | |
| Apr 14, 2022 (view filing) | Mar 24 | 21 daysLate | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −6.38K | $5.90 | −$37.6K | −2.2%283.1K after | |
| Apr 14, 2022 (view filing) | Mar 24 | 21 daysLate | Salzmann PeterChief Executive Officer | SSale | −19.2K | $5.90 | −$113.4K | −3.3%558.7K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Butchko Julia G.Chief Dev. & Tech. Officer | SSale | −55.3K | $7.25 | −$401.1K | −16.0%289.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Barnett Eva ReneeChief Financial Officer | SSale | −30.0K | $7.25 | −$217.2K | −14.8%172.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Salzmann PeterChief Executive Officer | SSale | −125.2K | $7.25 | −$907.4K | −17.8%578.0K after | |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Macias William L.Chief Medical Officer | SSale | −26.8K | $8.28 | −$222.0K | −12.0%197.3K after | |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Hughes Douglas J.Director | PPurchase | +18.2K | $8.24 | +$150.4K | +45.4%58.4K after | |
| Aug 20, 2021 (view filing) | Aug 20 | Same day | Migausky George VDirector | PPurchase | +7.00K | $7.65 | +$53.5K | +11.6%67.2K after | |
| Aug 16, 2021 (view filing) | Aug 13 | 3 days | Pande AtulDirector | PPurchase | +5.00K | $7.98 | +$39.9K | +12.4%45.2K after | |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Fromkin Andrew J.Director | PPurchase | +5.50K | $7.90 | +$43.5K | +13.7%45.7K after |